AI技術改寫資本流動邏輯,平安迎未來財報業績增長新變量
當下,一個由中國 AI 技術驅動的變量正悄然改寫資本流動的邏輯。DeepSeek 的橫空出世,不僅以突破性低成本模型顛覆了全球 AI 產業的競爭格局,更如同一把密鑰,解鎖了國際資本對中國資產的認知重構。
在開年以來一眾國際大行看好中國資產的浪潮中,DeepSeek 也為中國資產的重估添了一把柴,讓這股投資之火,越燒越旺。
據高盛研報,全球對沖基金今年以來大部分時間裏一直在大幅買入中國股票,2 月初買入力度為四個月以來最強。同時摩根士丹利、德意志銀行等多家投行也紛紛看好中國股市,認為 DeepSeek 等技術突破和政策紅利將進一步推動市場上升。
在 AI 掀起的這股投資熱浪中,高盛近期拆解中國股市 AI 投資框架中,平安卻赫然在列,其也是唯一一家名單中的險企。值得注意的是,平安旗下有 AI 醫療概念加持的平安好醫生近日表現尤為搶眼,四個交易日升幅超 40%。

事實上,中國平安獲的市場資金認可並不意外,AI也已經成為驅動公司未來業績增長的重要變量。
在科技領域特別是 AI 領域深耕多年,平安已經形成了強大的技術生態和創新能力。目前,中國平安擁有超 2 萬名科技開發人員,超 3000 名科學家的一流科技人才隊伍,集團專利申請數累計達 51700 項,位居國際金融機構前列。
從生產效率來看,2024 年前三季度,平安 AI 坐席服務量高達 13.4 億次,93% 的壽險保單實現秒級核保,平均理賠耗時僅 7.4 分鐘。其創新性推出的 "圖像定損" 技術將定損處理時效從小時級壓縮至分鐘級,將原本依賴人工判定的業務流程自動化,提高了理賠效率以及準確性。
在醫療健康養老領域,AI 也發揮着重要作用,而這也是旗下平安好醫生受市場熱捧的關鍵所在。比如,平安好醫生自主研發的 AI 輔助診療系統導診準確度超過 99%,輔助診斷準確率在 95% 以上,有助於減少醫護瑣碎工作,讓本就稀缺的醫療資源發揮出更大效用。
此外,近日平安好醫生相關負責人宣佈,在 "平安醫博通" 多模態大模型、"平安醫家人" 醫生工作台基礎上,公司已完成 DeepSeek 部署及部分場景應用驗證。作為當下最高效的 AI 大模型,平安率先接入 DeepSeek 無疑有助於提升診療效率、簡化醫患溝通流程、降低醫療成本,進而推動平安集團醫療領域佈局再上一個台階。
可以説,AI 技術在平安的廣泛應用,通過提升生產效率、降低生產成本,正成為平安未來財報業績的增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.